The idea that GFAP could be a good marker of pure progression has been considered because of its high levels in progressive forms, both in PPMS and secondary progressive MS (SPMS) without recent inflammatory activity [34, 65]. This evidence concerns the gene GFAP and primary progressive multiple sclerosis.